Recent clinical trials of proprotein convertase subtilisin-kexin (PCSK) type 9 inhibitors in coronary artery disease

Viola Mechirova, R. B. Singh, Ludovit Gaspar, Ernest Adeghate, Galal Elkilany, Jaipaul Singh

Research output: Contribution to journal › Editorial › peer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Recent clinical trials of proprotein convertase subtilisin-kexin (PCSK) type 9 inhibitors in coronary artery disease'. Together they form a unique fingerprint.